论文部分内容阅读
离剂量率腔内放射治疗，在临床上最大的缺点是合并症颇高，其中放射性肠炎在治疗上颇为棘手；近期放射性肠炎的发生率为4．6％一月％n］。我们自lop年4月一lop年12月采用本院放射生物室研制的纯中药复方制剂一2号（简称RP－11）脏器猫历预防放射性肠炎，现将其效果报道如下。l?
From the dose rate of endoluminal therapy, the biggest clinical disadvantage is that the complications are quite high, of which radiation enteritis is quite tricky to treat; the incidence of recent radiation enteritis was 4.6% in January% n]. We have used the Pure Chinese Medicine Compound Formulation No.2 (abbreviated as RP-11), which was developed by the Radiation Radiological Division of our hospital, to prevent radiation-induced enteritis in December of the year of lop in April of lop. The effect is reported below. l?